Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials

Back

ESC Premium Access

Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials

Session: Poster Session 6 - Lipid management and outcome

Topic: Lipid-Lowering Agents

Speaker: Doctor C. Ballantyne (Houston, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)

29 presentations

7 followers

6 more presentations in this session

Impact of statin therapy on long-term clinical outcomes between STEMI and NSTEMI after stent implantation

Speaker: Professor A. Her (Chuncheon, KR)

Access

Abstract

Adherence to statin therapy drives survival of patients with symptomatic peripheral artery disease

Speaker: Assistant Professor J. Dopheide (Thun, CH)

Access

Abstract

Slides

Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolemia phenotype

Speaker: Doctor E. Fountas (Athens, GR)

Access

Abstract

Slides

Eicosapentaenoic acid therapy is associated with decreased coronary plaque instability assessed using optical frequency domain imaging

Speaker: Doctor T. Konishi (Sapporo, JP)

Access

Abstract

Slides

Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials

Speaker: Doctor P. Guedeney (Paris, FR)

Access

Abstract

Slides

Access the full session

Poster Session 6 - Lipid management and outcome

Speakers: Doctor C. Ballantyne, Professor A. Her, Assistant Professor J. Dopheide, Doctor E. Fountas, Doctor T. Konishi...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources